Pruenster, Monika
Kurz, Angela R. M.
Chung, Kyoung-Jin
Cao-Ehlker, Xiao
Bieber, Stephanie
Nussbaum, Claudia F.
Bierschenk, Susanne
Eggersmann, Tanja K.
Rohwedder, Ina
Heinig, Kristina
Immler, Roland
Moser, Markus
Koedel, Uwe
Gran, Sandra
McEver, Rodger P.
Vestweber, Dietmar
Verschoor, Admar
Leanderson, Tomas
Chavakis, Triantafyllos
Roth, Johannes
Vogl, Thomas
Sperandio, Markus http://orcid.org/0000-0002-7689-3613
Article History
Received: 22 January 2015
Accepted: 13 March 2015
First Online: 20 April 2015
Competing interests
: T.L. is a part-time employee of Active Biotech that develops S100A9 inhibitors for the treatment of autoimmune diseases and cancer. The remaining authors declare no competing financial interests.